Canine CCL5/RANTES Antibody (676117)

R&D Systems | Catalog # MAB6045

R&D Systems

Key Product Details

Species Reactivity

Canine

Applications

Neutralization

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2B Clone # 676117
View all CCL5/RANTES Primary Antibodies »

Product Specifications

Immunogen

E. coli-derived recombinant canine CCL5/RANTES
Ser24-Ser91
Accession # Q8HYS0

Specificity

Detects canine CCL5/RANTES in direct ELISAs. In Western blots, no cross-reactivity with recombinant cotton rat CCL5, recombinant feline CCL5, recombinant human (rh) CCL5, 17, 18, recombinant mouse (rm) CCL5, 7, or 18 is observed. In direct ELISAs, approximately 25% cross‑reactivity with recombinant human CCL5 and no cross-reactivity with recombinant CCL5 from cotton rat, cat, or mouse is observed. No cross-reactivity with rhCCL1, 4, 11, 14, 16, 21, 23, 24, 26, 27, rmCCL6, 11, 21, 24, 26, or 27 is observed.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2B

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Canine CCL5/RANTES Antibody (676117)

Chemotaxis Induced by CCL5/RANTES and Neutralization by Canine CCL5/RANTES Antibody.

Chemotaxis Induced by CCL5/RANTES and Neutralization by Canine CCL5/RANTES Antibody.

Recombinant Canine CCL5/RANTES (Catalog # 6045-CR) chemoattracts the BaF3 mouse pro-B cell line transfected with human CCR5 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Canine CCL5/RANTES (10 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Canine CCL5/ RANTES Monoclonal Antibody (Catalog # MAB6045). The ND50 is typically 0.075-0.45 µg/mL.

Applications for Canine CCL5/RANTES Antibody (676117)

Application
Recommended Usage

Neutralization

Measured by its ability to neutralize CCL5/RANTES-induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CCR5. The Neutralization Dose (ND50) is typically 0.075-0.45 µg/mL in the presence of 10 ng/mL Recombinant Canine CCL5/RANTES.

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Sterile PBS to a final concentration of 0.5 mg/mL. For liquid material, refer to CoA for concentration.

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CCL5/RANTES

CCL5, also known as RANTES (Regulated upon Activation, Normal T cell Expressed and presumably Secreted), is an 8 kDa beta ‑chemokine that plays a primary role in the inflammatory immune response by means of its ability to attract and activate leukocytes (1‑3). Human and mouse RANTES exhibit cross‑species activity on human and mouse cells (4). Mature canine CCL5 shares 74%‑84% amino acid sequence identity with cotton rat, feline, human, mouse, and rat CCL5. CCL5 is secreted by many cell types at inflammatory sites, and it exerts a wide range of activities through the receptors CCR1, CCR3, CCR4, and CCR5 (5, 6). Inflammatory responses can be impaired by the sequestration of CCL5 by the cytomegalovirus protein US28 (7). In humans, CCR5 binding to CCL5 inhibits the infectivity of R5 (M-tropic) but not X4 (T-tropic) strains of HIV-1 (8). The two N-terminal residues of CCL5 can be removed by CD26/DPPIV, generating a protein that functions as a chemotaxis inhibitor and more effectively blocks M-tropic HIV-1 infection of monocytes (9). Oligomerization of CCL5 on glycosaminoglycans is required for CCR1-mediated leukocyte adhesion and activation as well as CCL5’s interaction with the chemokine CXCL4/PF4 (10‑12). The deposition of CCL5 on activated vascular endothelial cells is crucial for monocyte adhesion to damaged vasculature, but CCL5 oligomerization is not required for the extravasation of adherent leukocytes (13‑15). CCL5 is upregulated in breast cancer and promotes tumor progression through the attraction of proinflammatory macrophages in addition to its actions on tumor cells, stromal cells, and the vasculature (16).

References

  1. Schall, T.J. et al. (1990) Nature 347:669.
  2. Bacon, K.B. et al. (1995) Science 269:1727.
  3. Fischer, F.R. et al. (2001) J. Immunol. 167:1637.
  4. Schall, T.J. et al. (1992) Eur. J. Immunol. 22:1477.
  5. Appay, V. and S.L. Rowland-Jones (2001) Trends Immunol. 22:83.
  6. Levy, J.A. (2009) J. Immunol. 182:3945.
  7. Randolph-Habecker, J.R. et al. (2002) Cytokine 19:37.
  8. DeVico, A.L. and Gallo, R.C. (2004) Nat. Rev. Microbiol. 2:401.
  9. Proost, P. et al. (1998) J. Biol. Chem. 273:7222.
  10. Appay, V. et al. (1999) J. Biol. Chem. 274:27505.
  11. Proudfoot, A.E.I. et al. (2003) Proc. Natl. Acad. Sci. 100:1885.
  12. von Hundelshausen, P. et al. (2005) Blood 105:924.
  13. von Hundelshausen, P. et al. (2001) Circulation 103:1772.
  14. Zernecke, A. et al. (2008) Arterioscler. Thromb. Vasc. Biol. 28:1897.
  15. Baltus, T. et al. (2003) Blood 102:1985.
  16. Soria, G. and A. Ben-Baruch (2008) Cancer Lett. 267:271.

Alternate Names

RANTES, SISd

Entrez Gene IDs

6352 (Human); 20304 (Mouse); 403522 (Canine); 493689 (Feline)

Gene Symbol

CCL5

UniProt

Q8HYS0

Additional CCL5/RANTES Products

Product Documents for Canine CCL5/RANTES Antibody (676117)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Canine CCL5/RANTES Antibody (676117)

For research use only

Customer Reviews for Canine CCL5/RANTES Antibody (676117)

There are currently no reviews for this product. Be the first to review Canine CCL5/RANTES Antibody (676117) and earn rewards!

Have you used Canine CCL5/RANTES Antibody (676117)?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 for a review with an image

$10/€7/£6/$10CAN/¥1110 for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies